| Presenter |
Poster link (or abstract as available) |
| Adalbert, Ms. Jenna |
Increased COVID-19 Mortality Risk |
| Ahmed, Dr Asim |
Karius Test |
| Ahn, Dr. Hyojin |
Hypogammaglobulinemia |
| Al Agha, Dr Rawan |
Fusarium solani |
| Bandy, Ms Emma |
Recombinant Zoster vaccine |
| Borg, Dr Claire |
Safety of recombinant Zoster vaccine |
| Borg, Dr Claire |
Immunogenicity of recombinant zoster vaccine |
| Chai, Dr Khai Li |
Newly diagnosed multiple myeloma |
| Cho, Sung-yeon |
Hemorrhagic Cystitis after Allogeneic HSCT |
| Cochran, Willa |
Multidisciplinary Approach to Prevention of CMV |
| De Oliveira Mota, Dr Fernanda |
SARS COV-2 infection |
| Dharan, Dr Nila |
Multispecies outbreak of Nocardia infections |
| Douglas, Dr Abby * |
Burden and outcomes of neutropenic fever |
| Flanagan, Shawn |
Renal Function in the Phase 2 STRIVE Trial of Rezafungin |
| Gardiner, Dr Brad ** |
Quantiferon®-CMV prior to primary prophylaxis discontinuation |
| Gardiner, Dr Brad |
Optimizing antibiotic prophylaxis |
| Griffin, Dr David |
Cryptococcus neoformans var grubii meningoencephalitis |
| Haddadin, Dr Zaid |
Lab Confirmed Influenza in Vaccinated Pediatric HSCT Recipients |
| Ho, Su Ann |
Refractory and resistant cytomegalovirus infection in allogeneic HSCT |
| Katupitiya, Dr Dumindu |
Treatment Resistant Polyarticular Mycobacterium Intracellulare Infection |
| Kim, Dr. Si-hyun |
Serum endocan and Cathepsin G-cleaved endocan in febrile neutropenia |
| Luu, Dr Sarah |
Prevention of Asplenic Pneumococcal Infection (PAPI) |
| Luu, Miss Melissa |
Patterns and outcomes of infections in patients with lung cancer |
| Madney, Dr Youssef |
Candidemia Among Pediatric Cancer Patients |
| Maertens, Dr Johan *** |
Empiric vs pre-emptive/diagnostic driven antifungal strategy in neutropenic |
| Mendez, Gustavo |
Sources of infection and bloodstream isolates in patients with acute leukemia |
| Mendez, Gustavo |
Neutropenic enterocolitis in patients with acute leukemia |
| Ogimi, Dr Chikara |
Factors associated with viral lower respiratory tract infection in allogeneic HSCT |
| Oikonomopoulou, Dr. Zacharoula |
Partial Autosomal Dominant STAT-1 Deficiency |
| Oltolini, MD Chiara |
Mycobacterium tuberculosis complex infection in children |
| Park, Dr. Hwanhee |
Decrease of respiratory virus infection in paediatric pts during COVID-19 |
| Safe, Dr Liam |
Tracking Functional Immune Recovery Following Allogeneic HSCT |
| Sait, Dr. Afrah |
Outcomes in SOT Recipients Treated With Newer Therapies for COVID-19 |
| Sandison, Dr Taylor |
Safety and Efficacy of Rezafungin in Immunocompromised Patients |
| Sandison, Dr Taylor |
Extended Rezafungin In a Murine Model Of Pneumocystis Pneumonia |
| Selby, Philip |
Analysis of antifungal prophylaxis in pts undergoing allogeneic HSCT |
| Silva, Dr Adriana |
Ceftazidime-avibactam treating MDR Klebsiela pneumoniae in child HSCT |
| Silva, Dr Adriana |
SARS-CoV-2 infection in children and adolescents with cancer |
| Smibert, Olivia |
Pseudotumor presentation of CMV disease |
| Stella, Ms Maureen Miracle |
Milk Lactoferrin: A Novel Antifungal with Remarkable Azole Potentiation |
| Sundac, Dr Lana |
Droplet digital PCR for the quant detection of BK polyomavirus in blood |
| Tey, Ms Amanda |
Risk factors for invasive fungal infection in 5-azacitidine treated patients |
| Tio, Dr Shio Yen |
Olorofim for Severe Disseminated Lomentospora prolificans infection |
| Valentine, Mr. Jake |
Evaluating burden of healthcare-associated infections in Victorian cancer pts |
| Varshney, Mr. Karan |
Risk Factors for COVID-19 Mortality Among People Living with HIV |
| Wong, Michael |
Cef-Taz Treatment Outcomes in IC pts with MDR Pseudomonas aeruginosa |
| Yeoh, Dr Daniel |
Febrile neutropenia in paediatric oncology and HSCT patients |
| Yoon, Dr Yoonsun |
Successful treatment of Ebstein-Barr virus-related acute retinal necrosis |
| Zimmet, Dr. Alex |
Pathophysiological signatures of bloodstream infection in transplant |
